Targeted breast cancer treatment approved for routine NHS use
By Liz Wells 11 April 2025
NICE is recommending capivasertib with fulvestrant to treat women with advanced breast cancer, which means the drug will be funded immediately through the Cancer Drugs Fund.
The age of equalitarianism
14 October 2024
Increasing workforce supply and disease awareness and prevention - at pace
Government investment to boost AI cancer research at Leeds Teaching Hospitals
By Liz Wells 08 October 2024
The National Pathology Imaging Co-operative (NPIC) at Leeds Teaching Hospitals NHS Trust will receive £5.1m from the government to improve data infrastructure that will aid cancer and disease resea...
Team Co-ordinator
£29,314 - £34,997 per annum
Hybrid working – allocated to offices in Coventry or York£29,314 - £34,997 per annum
Social Worker
Band G SCP 32-37 (£41,511 - £46,731 per annum)
Sandwell, West MidlandsBand G SCP 32-37 (£41,511 - £46,731 per annum)
Team Co-ordinator
£29,314 - £34,997 per annum
Hybrid working – allocated to offices in Coventry or York£29,314 - £34,997 per annum
Social Worker
Band G SCP 32-37 (£41,511 - £46,731 per annum)
Sandwell, West MidlandsBand G SCP 32-37 (£41,511 - £46,731 per annum)
©2024 Hemming Group Limited. Registered in England and Wales. Registered No: 490200. VAT number GB342 023 408
